A q t i c h o l i n e r g~c d r u g s have 2hown good b r o n c h o d i l a t i n g p r o p e r t i e s i n both a d u l t s and c h i l d r e n with asthma. When combined with a b r o q c h o d i l a t o r , a summation e f f e c t h a s sometimes been seen3.
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The u s e of a s t a
n d a r d metered a e r o s o l needs c o n s i d e r a b l e s k i l l and c o o r d i n a t i o n , which i s extremely d i f f i c u l t f o r c h i l d r e n . To ensure s a t i s f a c t o r y i n h a l a t i o n of drugs s e v e r a l d e v i c e s have been developed t o overcome t h i s problem. A s t u d y t o compare t h e c l i n i c a l and bronchod i l a t o r e f f e c t of T e r b u t a l i n e -s u l p h a t e a d m i n i s t e r e d v i a a nebuhaler (TN), w i t h t h a t of Salbutamol powder a d m i n i s t e r e d v i a a r o t a h a l e r (SR)
, was c a r r i e d o u t i n 10 boys w i t h s t a b l e moderate asthma; ager a n g e 8-13 y e a r s . The e f f e c t s were measured by means of spirometry and c l i n i c a l assessment i n a double-blind randomized cross-over f a s h i o n . With both drugs cumulative dose-response c u r v e s were e s t a b l i s h e d . With i n t e r v a l s of 20 minutes 0.25 mg of TN o r 0.2 mg of SR was administered up t o a maximal dose of 1.0 mg of TN and 0.8 mg of SR. Lungfunctiont e s t s (FVC, FEVl, MMEF, MEF 50%, MEF 75%, PEFR) were performed 15 minutes a f t e r each a d m i n i s t r a t i o n of drug.
I n a l l c h i l d r e n s i g n i f i c a n t b r o n c h o d i l a t a t i o n was s e e n a f t e r 0.5 mg of TN o r 0.4 mg of SR. The maximal b r o n c h o d i l a t o r e f f e c t of SR was s i g n i f i c a n t l y l a r g e r than t h a t of TN, a s can be shown f o r MMEF, MLF 50% and MEF 75%; t h i s could n o t be shown f o r FEVl and PEER. C l i n i c a ll y s i d e -e f f e c t s d i d n o t occur. For a t l e a s t 5 h o u r s a f t e r t h e l a s t dosc b r o n c h o d i l a t a t i o n was s e e n a s shown by h o u r l y PEFR-measurements. S i n c e a good b r o n c h o d i l a t o r e f f e c t was shown w i t h t h e use of a nebuh a l e r we conclude i t t o be a good d e v i c e f o r i n h a l a t i o n t h e r a p y i n c h i l d r e n , c l i n i c a l l y comparable t o t h e r o t a h a l e r ; i n o u r group, howe v e r , b e t t e r b r o n c h o d i l a t o r e f f e c t was achieved w i t h t h e r o t a h a l e r . BROMmE. 146 N M Wilson, S Green, C Coe, P J Barnes, M S i l v e m a n .
DURATION OF ACTION OF OXITROPIUM
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Vagal r e f l e x e s may b e a f a c t o r i n noctwzndl asthma and t h e r e f o r e t r e a t m e n t w i t h a l o n g a c t i n g a n t i c h o l i n e r g l c would b e a p p r o p r i a t e .
!Phis s t u d y waa d e s i w e d t o a s s e s s t h e d u r a t i o n a n d d e g r e e of p r o t e c t i o n a f f o r d e d b y t h e W e d a n t i c h o l i n e r g i c agent M t r o p i u m bromide (OB) against methacholine-induced b r o n c h o c o n s t r i c t i o n . Ten
s u b j e c t s (6 c h i l d r e n , 4 a d u l t s ) , w i t h a wide spectrum of clinical asthma, were s t u d i e d . A f t e r a c o n t r o l methacholine i n h a l a t i o n c k s l l e n g e , OB 200 mcg o r p l a c e b o were given d o u b l e -b l i n d and methacholine chaIllenges were r e p e a t e d 1 3 and 6 h o u r s l a t e r . There was a s t a t i s t i c a l l y s i g n i f i c a n t (pt0.01) i n c r e a s e in methacholine PC at 6 h o u r s a f t e r 0B 200 m c p This however o n l y r e p r e s e n t e d -r12&lution i n c r e a s e i n F'2 in 4 s u b j e c t s and i n 1 s u b j e c t t h e PCp0 had r e t u r n e d t o w i t h i n 1 &Pution b y 3 hours. The d e g r e e and d u r a t i o n o f p r o t e c t i o n was o n l y weakly r e l a t e d t o s e n s i t i v i t y t o methacholine, b a s e l i n e lung f u n c t i o n and t h e d e g r e e o f b r o n c h o d i l a t i o n induced.
The s e v e n s u b j e c t s n o t f u l l y p r o t e c t e d were r e t e s t e d u s i n g OB 100 and 400 mcg o n two h t h e r days, b u t n o c l e a r d o s e dependent r e s p o n s e c o u l d b e demonstrated.
The prolonged a n t i c h o l i n e r g i c a c t i o n which was s e e n i n some s u b j e c t s s w a t s t h a t i n h a l e d M t r o p i u m bromide may b e useful i n t r e a t i n g n o c t u r n a l asthma. The inhibition of asthmatic responses a f t e r antigenic challenges and of exercise-induced asthma by inhalation of sodium cromoglycate (DSCG) has been clearly demonstrated. Its short-term effect on acetylcholine inhalation challenge remains controversial. Twelve adolescent asthmatics in a clinical steady s t a t e (7 female, 5 male; aged 15-19 years; both extrinsic and intrinsic type) with proven bronchial hyperreactivity underwent acetylcholine inhalation t e s t s (AIT) on five consecutive days: On day 1, a f t e r baseline assessment of spirometry (FEV 1 ) they inhaled increasing doses of acetylcholine (1 mgl0.5 ml, 1 mglml, 10 mglml) t o measure the provocative dose causing a fall in FEV 1 of 2 0 % (PD20).
On days 2 , 3 , 4 , and 5 -a f t e r baseline spirometry had confirmed that FEV 1 was within 1 0 % of day 1 initial assessment -in a double blind intraindividual randomized study AIT was repeated 15 minutes a f t e r inhalation of DSCG 2 mg plus reproterol 1 mg, DSCG 2 mg, reproterol 1 mg, and placebo, respectively (two puffs of pressurizd aerosol). The combination of reproterol and DSCG proved t o have the best a c u t e protective e f f e c t on acetylcholine induced bronchoconstriction in adolescent asthmatics, giving t h e best or second best protection in 11 out of 12 individuals, followed by reproterol alone. Therefore it is possible t o reduce bronchial hyperreactivity with t h e combination medication a f t e r single use in adolescent asthmatics. R e s u l t s were a n a l y s e d i n 24 s u b j e c t s who ccmpleted t h e study. S t a t is t i c a l a n a l y s i s allowed f o r t r e a t m n t o r d e r and seasonal e f f e c t s . Sign i f i c a n t r e s u l t s In favour o f SCG were o b t a i n e d f o r n i g h t cough, day a c t i v i t y , p e r c e n t a g e o f s y n p t m f r e e d a y s and o v e r a l l a s t h n a s e v e r i t y . During a c t i v e t r e a t m e n t t h e r e was no r e d c r t i o n i n h o s p i t a l admission r a t e o r i n t r a v e n o u s d r u g s used. The wheeze s c o r e i n t h e week a f t e r a n upper r e s p i r a t o r y i n f e c t i o n was not redcred d u r i n g SCG t r e a t m e n t .
Nebulised SCG is t e d i o u s p r o p h y l a c t i c t r e a t m e n t f o r t h e v e r y young a s t h m t i c c h i l d , but m r t h a t r i a l when o t h e r t h e r a p i e s have f a i l e d . when t a k e n o r a l l y . M6B 22,948 i s a n o r a l l y absorbed mast c e l l s t a b i l i s e r which h a s p r e v i o u s l y been shown t o block e x e r c i s e induced asthma i n a d u l t s . We conducted a t r i a l i n which 15 c h i l d r e n w i t h asthma each undertook t h r e e e x e r c i s e c h a l l e n g e s . They were p r e t r e a t e d w i t h e i t h e r MLB 22,948 o r placebo, g i v e n double-blind, i n randomly a l l o c a t e d o r d e r , p r i o r t o t h e second and t h i r d c h a l l e n g e s .
Our r e s u l t s f a i l e d t o show a p r o t e c t i v e e f f e c t of MLB 22,948 a g a i n s t e x e r c i s e induced asthma b u t t h e p o s s i b l e reasons f o r t h e d i s c r e p a n c y w i t h t h e p r e v i o u s t r i a l w i l l be d i s c u s s e d .
